Posted on 20/07/2006 in Medical Company Financials Bard, the medical equipment company, has reported an 11 per cent increase in net total sales, with sales performance outside the US increasing by five per cent.
However, the company reported that net income and diluted earnings decreased by five and four per cent respectively over the second quarter of 2006, but adjusting for certain items that affected comparability to the same period last year, the net income actually rose by 13 per cent, up to $90.8 million (49.1 million pounds).
Sales growth in the oncology side of the business was particularly strong over the half-year, increasing by 17 per cent, while vascular and urology product sales also increased strongly during the last quarter.
Timothy M Ring, Bard's chairman and chief executive officer, remarked: "Results for the quarter were again strong. Revenue in all four of our businesses grew at or above our expectations reflecting the productivity of our new product pipeline."
"We continue to be pleased with the execution of our strategy, remaining focused on our goal to deliver double-digit revenue growth," he added.
Bard's UK operations are based in Crawley, West Sussex. The company produces products to aid in the treatment of a range of oncological, vascular and urological disorders, as well as providing surgical speciality products.
 © Adfero LtdOther news stories from 20/07/2006
Read more in the Zenopa News Archive
How this news is generated
|
